In addition to cutting most of its staff, including two C-suite executives, Leap Therapeutics is winding down research and development activities and considering a sale or partnership opportunities.
Leap Slashes 75% of Workforce, Explores Strategic Options Read More »
Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared updates on its implantable glucose sensors.
ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors Read More »
The recall affects 15 Carestation models and more than 14,000 individual devices.
GE Healthcare recalls Carestation devices over ventilation failure risk Read More »
Providers will need to make difficult decisions about what services they offer and where amid growing headwinds, according to a new report from S&P Global Ratings.
Maintaining healthcare access and affordability increasingly difficult: report Read More »
In May, Revolution Medicines projected its cash and equivalents of $2.1 billion would last into the second half of 2027. With new funding from Royalty Pharma, the biotech has withdrawn that runway end date.
Revolution Establishes Endless Cash Runway With $2B Royalty Pharma Deal Read More »
Isaralgagene civaparvovec is a “potential best-in-class gene therapy for Fabry disease,” according to analysts at H.C. Wainwright. Sangamo plans to use pivotal Phase I/II data to build an accelerated approval case for the asset.
Sangamo’s ‘Positive’ Phase I/II Data for Fabry Gene Therapy Opens Path to FDA Read More »
Eli Lilly’s bimagrumab led to weight loss that was due almost entirely to fat reduction when combined with semaglutide, marketed by rival Novo Nordisk as Wegovy. BMO Capital Markets called the data “impressive” while raising concerns about the antibody’s safety profile.
Lilly Antibody Protects Patients From Losing Muscle While Taking Novo’s Wegovy Read More »
The star of Monday’s deal is gusacitinib, a small-molecule drug that Formation is developing for chronic hand eczema. Sanofi will explore additional indications for gusacitinib in a Phase I study.
In latest AI Play, Sanofi Bets $630M+ for Formation Bio’s JAK/SYK Blocker Read More »
La inteligencia artificial (IA) ya se aplica en múltiples industrias. En el campo de las apuestas, su uso ha crecido notablemente en los últimos tres años. Plataformas deportivas y de casino incorporan análisis automáticos, predicción de resultados …
La relación entre el fútbol local y las apuestas deportivas digitales ha crecido de forma constante en los últimos años. En El Salvador, los campeonatos nacionales han alimentado una cultura de participación tanto presencial como en línea. El acces …
Fútbol salvadoreño y participación digital: apuestas que siguen cada jugada Read More »
